Japan Pharmas Enlist Government In Fight Against Fake Drugs
This article was originally published in PharmAsia News
Japanese drug makers, including subsidiaries of multinational corporations, are in the forefront of an effort to crack down on the spread of counterfeit drugs in the country. Some of the major makers count success in getting Japanese authorities to block the trade in counterfeit erectile dysfunction drugs in the past two years. The effort led to 123,000 fake Pfizer Viagra (sildenafil citrate) pills alone to be seized. A Japanese professor notes the spread of fake drugs could cause a loss of credibility for genuine medicines. (Click here for more
You may also be interested in...
Ipsen’s business strategy calls for accessing external innovation across its pipeline, combined with geographic expansion, realizing the unmet potential of its marketed products and business efficiencies in manufacturing and operations.
The proposal, which would increase capacity for pandemic supplies, is similar to ideas President Trump embraced pre-pandemic.
Sanofi has named the head of its new API business; Sweden's Enzymatica has hired talent from J&J and L'Oreal; and Bayer has a new transformation officer.